Relationship Between Hyperventilation Syndrome and SARS-CoV-2 Infection

A Cross-sectional Study : Is There a Relationship Between Hyperventilation Syndrome and History of Acute SARS-CoV-2 Infection?

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT05224830

Acronym

Hypercovid

Enrollment

2846

Registered

2022-02-04

Start date

2021-01-01

Completion date

2022-07-01

Last updated

2022-09-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19, Hyperventilation Syndrome

Keywords

covid-19, dyspnea, Hyperventilation Syndrome

Brief summary

Following an acute COVID-19 infection, many patients suffer from long lasting physical symptoms that may greatly impair quality of life. Persisting dyspnea and other functional respiratory complaints could evoke Hyperventilation Syndrome (HVS) as a putative contributor of the long-COVID presentation in COVID-19 survivors. We aimed to assess the possible relationship between a HVS and previous acute SARS-CoV-2 infection.

Interventions

OTHERNijmegen questionnaire score

We collected the Nijmegen Questionnaire in order to diagnosis of Hyperventilation Syndrome

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Read and speak French * Perform a pulmonary function test

Exclusion criteria

\- incomplete questionnaire or inability to obtain an interpretable lung function assessment

Design outcomes

Primary

Measure	Time frame
Assess the relationship between a hyperventilation syndrome and previous acute SARS-CoV-2 infection.	Nijmegen questionnaire during 15 minutes (cross-sectional monocentric study)

Secondary

Measure	Time frame
Assess the relationship between a hyperventilation syndrome and dyspnea	Nijmegen questionnaire during 15 minutes (cross-sectional monocentric study)

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026